Cargando…

A hierarchical prognostic model for Co-diabetes pancreatic adenocarcinoma

BACKGROUND: Co-diabetes pancreatic adenocarcinoma has a poorer prognosis than pancreatic adenocarcinoma without diabetes. This study aimed to develop a reliable prognostic model for patients with co-diabetes pancreatic adenocarcinoma. METHOD: Overall, 169 patients with co-diabetes pancreatic adenoca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Zelong, Liu, Chunsheng, Ma, Zuyi, Li, Zhenchong, Wang, Shujie, Chen, Yubin, Han, Mingqian, Huang, Shanzhou, Zhou, Qi, Zhang, Chuanzhao, Hou, Baohua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663840/ https://www.ncbi.nlm.nih.gov/pubmed/38027595 http://dx.doi.org/10.1016/j.heliyon.2023.e21642

Ejemplares similares

Prognostic Nomogram for Patients With Pancreatic Ductal Adenocarcinoma of Pancreatic Head After Pancreaticoduodenectomy
por: Zhuang, Hongkai, et al.
Publicado: (2021)

ZMAT1 acts as a tumor suppressor in pancreatic ductal adenocarcinoma by inducing SIRT3/p53 signaling pathway
por: Ma, Zuyi, et al.
Publicado: (2022)

Characterization of the prognostic and oncologic values of ITGB superfamily members in pancreatic cancer
por: Zhuang, Hongkai, et al.
Publicado: (2020)

Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas
por: Zhuang, Hongkai, et al.
Publicado: (2021)

Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma
por: Ma, Zuyi, et al.
Publicado: (2021)

CMTM3 Overexpression Predicts Poor Survival and Promotes Proliferation and Migration in Pancreatic Cancer
por: Zhou, Zixuan, et al.
Publicado: (2021)

Identification by genetic algorithm optimized back propagation artificial neural network and validation of a four-gene signature for diagnosis and prognosis of pancreatic cancer
por: Li, Zhenchong, et al.
Publicado: (2022)

Identification of MBOAT2 as an Unfavorable Biomarker Correlated with KRAS Activation and Reduced CD8(+) T-Cell Infiltration in Pancreatic Cancer
por: Li, Zhenchong, et al.
Publicado: (2022)

Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer
por: Ma, Zuyi, et al.
Publicado: (2021)

SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma
por: Ma, Zuyi, et al.
Publicado: (2021)

Genome-Wide CRISPR/Cas9 Library Screening Identified that DUSP4 Deficiency Induces Lenvatinib Resistance in Hepatocellular Carcinoma
por: Huang, Shanzhou, et al.
Publicado: (2022)

A Novel Prognostic Nomogram for Gallbladder Cancer after Surgical Resection: A Single-Center Experience
por: Ma, Zuyi, et al.
Publicado: (2021)

Prognostic values and immune suppression of the S100A family in pancreatic cancer
por: Zhuang, Hongkai, et al.
Publicado: (2021)

A four prognosis-associated lncRNAs (PALnc) based risk score system reflects immune cell infiltration and predicts patient survival in pancreatic cancer
por: Zhuang, Hongkai, et al.
Publicado: (2020)

B3GNT3 overexpression promotes tumor progression and inhibits infiltration of CD8(+) T cells in pancreatic cancer
por: Zhuang, Hongkai, et al.
Publicado: (2020)

Prognostic Stratification Based on a Novel Nomogram for Solitary Large Hepatocellular Carcinoma After Curative Resection
por: Zhuang, Hongkai, et al.
Publicado: (2020)

Incidental intraoperative finding of gallbladder duplication in a patient with a choledochal cyst
por: Zhuang, Hongkai, et al.
Publicado: (2020)

Neo-adjuvant chemotherapy followed by radical resection for primary borderline resectable unicentric Castleman disease: a case report
por: Zhuang, Hongkai, et al.
Publicado: (2020)

GTF2IRD1 overexpression promotes tumor progression and correlates with less CD8(+) T cells infiltration in pancreatic cancer
por: Zhuang, Hongkai, et al.
Publicado: (2020)

Obg-like ATPase 1 (OLA1) overexpression predicts poor prognosis and promotes tumor progression by regulating P21/CDK2 in hepatocellular carcinoma
por: Huang, Shanzhou, et al.
Publicado: (2020)

AQP5 Is a Novel Prognostic Biomarker in Pancreatic Adenocarcinoma
por: Chen, Guo, et al.
Publicado: (2022)

An immune-related gene prognostic risk index for pancreatic adenocarcinoma
por: Su, Yang, et al.
Publicado: (2022)

Down‐regulated lncRNA SBF2‐AS1 in M2 macrophage‐derived exosomes elevates miR‐122‐5p to restrict XIAP, thereby limiting pancreatic cancer development
por: Yin, Zi, et al.
Publicado: (2020)

Establishment and validation of an AJCC stage- and histologic grade-based nomogram for pancreatic neuroendocrine tumors after surgical resection
por: Zhang, Chuanzhao, et al.
Publicado: (2019)

Regulation of iron metabolism and ferroptosis in cancer stem cells
por: Wang, Hailiang, et al.
Publicado: (2023)

Identification of SPRYD4 as a tumour suppressor predicts prognosis and correlates with immune infiltration in cholangiocarcinoma
por: Ma, Zuyi, et al.
Publicado: (2023)

Prognostic Significance of Erythropoietin in Pancreatic Adenocarcinoma
por: Welsch, Thilo, et al.
Publicado: (2011)

NMU Is a Poor Prognostic Biomarker in Patients with Lung Adenocarcinoma
por: Tang, Yan, et al.
Publicado: (2021)

Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head
por: Wu, Chao, et al.
Publicado: (2021)

Modeling Prognostic Factors in Resectable Pancreatic Adenocarcinomas
por: Botsis, Taxiarchis, et al.
Publicado: (2010)

Prognostic Significance of Maspin in Pancreatic Ductal Adenocarcinoma
por: Lim, Yun Jeong, et al.
Publicado: (2004)

Expression and prognostic analyses of SCAMPs in pancreatic adenocarcinoma
por: Mao, Feiyu, et al.
Publicado: (2021)

Expression and prognostic impact of FZDs in pancreatic adenocarcinoma
por: Li, Yang, et al.
Publicado: (2021)

An Automated Prognostic Model for Pancreatic Ductal Adenocarcinoma
por: Vezakis, Ioannis, et al.
Publicado: (2023)

LHX3 is an early stage and radiosensitivity prognostic biomarker in lung adenocarcinoma
por: Lin, Xin, et al.
Publicado: (2017)

Genome-Wide Profiling of Prognostic Alternative Splicing Pattern in Pancreatic Cancer
por: Yu, Min, et al.
Publicado: (2019)

Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1
por: Yin, Zi, et al.
Publicado: (2021)

Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma
por: Agrawal, Shefali
Publicado: (2017)

Minimally Invasive Surgery for Intracerebral and Intraventricular Hemorrhage
por: Zheng, Zelong, et al.
Publicado: (2022)

CXCL10 is a prognostic marker for pancreatic adenocarcinoma and tumor microenvironment remodeling
por: Nie, Yuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h6qemojf7v8na0h48hbgeduigb